Barr Confirms Patent Challenge of Aggrenox(R) (FinanzNachrichten)
WOODCLIFF LAKE, N.J., July 12 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, ( Nachrichten ) Inc. today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patent listed by Boehringer Ingelheim in connection with its Aggrenox(R) (Aspirin/Extended- Release Dipyridamole) 25 mg/200 mg capsules.

Critters that Crawl Under Toenails Face More Attackers as FDA Approves Generics (Senior Journal)
July 10, 2007 Everyone has cringed seeing those mean looking little critters on the TV commercial that crawl under toenails to make their homes. Many may have wondered why these ads for Lamisil tablets ran so often. It is because almost 40% of older adults battle nail fungus infection.

Aurobindo Pharma Selects MetricStream For Compliance And Quality (PharmaceuticalOnline)
MetricStream, Inc., the market leader in enterprise-wide Governance, Risk, Compliance (GRC) and Quality Management solutions, announced that Aurobindo Pharma (INDIA: AUROPHARMA) has selected the MetricStream solution to automate its compliance processes for meeting FDA cGMP regulations.